Qiulei Zhang , Jingxiao Zhang , Yu Zhang , Yujie Sui , Yang Du , Longfei Yang , Yongjie Yin
{"title":"广藿香醇对白色念珠菌的抗真菌和抗生物膜活性。","authors":"Qiulei Zhang , Jingxiao Zhang , Yu Zhang , Yujie Sui , Yang Du , Longfei Yang , Yongjie Yin","doi":"10.1016/j.ijmm.2023.151596","DOIUrl":null,"url":null,"abstract":"<div><p>The opportunistic fungal pathogen <em>Candida albicans</em> could cause severe clinical outcomes which could be exacerbated by the scarcity of antifungals. The capacity of <em>C. albicans</em> to form biofilms on medical devices that are hard to eradicate, further deepen the need to develop antifungal agents. In this study, we, for the first time, showed that patchouli alcohol (PA) can inhibit the growth of multiple <em>C. albicans</em> strains, as well as four other <em>Candida</em> species, with MICs of 64 μg/mL and MFCs from 64 to 128 μg/mL. The biofilm formation and development, adhesion, yeast-to-hyphal transition and extracellular polysaccharide of <em>C. albicans</em> can be inhibited by PA in a concentration-dependent manner. Confocal microscopy analyses of cells treated with PA showed that PA can increase the membrane permeability and intracellular reactive oxygen species (ROS) production. In <em>C. elegans</em>, PA did not influence the survival below 64 μg/mL. In this study PA demonstrated antifungal and antibiofilm activity against <em>C. albicans</em> and our results showed the potential of developing PA to fight <em>Candida</em> infections.</p></div>","PeriodicalId":50312,"journal":{"name":"International Journal of Medical Microbiology","volume":"314 ","pages":"Article 151596"},"PeriodicalIF":4.5000,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1438422123000243/pdfft?md5=87e6522f90d3784677943e5fdcd637cd&pid=1-s2.0-S1438422123000243-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Antifungal and anti-biofilm activities of patchouli alcohol against Candida albicans\",\"authors\":\"Qiulei Zhang , Jingxiao Zhang , Yu Zhang , Yujie Sui , Yang Du , Longfei Yang , Yongjie Yin\",\"doi\":\"10.1016/j.ijmm.2023.151596\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The opportunistic fungal pathogen <em>Candida albicans</em> could cause severe clinical outcomes which could be exacerbated by the scarcity of antifungals. The capacity of <em>C. albicans</em> to form biofilms on medical devices that are hard to eradicate, further deepen the need to develop antifungal agents. In this study, we, for the first time, showed that patchouli alcohol (PA) can inhibit the growth of multiple <em>C. albicans</em> strains, as well as four other <em>Candida</em> species, with MICs of 64 μg/mL and MFCs from 64 to 128 μg/mL. The biofilm formation and development, adhesion, yeast-to-hyphal transition and extracellular polysaccharide of <em>C. albicans</em> can be inhibited by PA in a concentration-dependent manner. Confocal microscopy analyses of cells treated with PA showed that PA can increase the membrane permeability and intracellular reactive oxygen species (ROS) production. In <em>C. elegans</em>, PA did not influence the survival below 64 μg/mL. In this study PA demonstrated antifungal and antibiofilm activity against <em>C. albicans</em> and our results showed the potential of developing PA to fight <em>Candida</em> infections.</p></div>\",\"PeriodicalId\":50312,\"journal\":{\"name\":\"International Journal of Medical Microbiology\",\"volume\":\"314 \",\"pages\":\"Article 151596\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2023-12-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1438422123000243/pdfft?md5=87e6522f90d3784677943e5fdcd637cd&pid=1-s2.0-S1438422123000243-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Medical Microbiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1438422123000243\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Medical Microbiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1438422123000243","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
Antifungal and anti-biofilm activities of patchouli alcohol against Candida albicans
The opportunistic fungal pathogen Candida albicans could cause severe clinical outcomes which could be exacerbated by the scarcity of antifungals. The capacity of C. albicans to form biofilms on medical devices that are hard to eradicate, further deepen the need to develop antifungal agents. In this study, we, for the first time, showed that patchouli alcohol (PA) can inhibit the growth of multiple C. albicans strains, as well as four other Candida species, with MICs of 64 μg/mL and MFCs from 64 to 128 μg/mL. The biofilm formation and development, adhesion, yeast-to-hyphal transition and extracellular polysaccharide of C. albicans can be inhibited by PA in a concentration-dependent manner. Confocal microscopy analyses of cells treated with PA showed that PA can increase the membrane permeability and intracellular reactive oxygen species (ROS) production. In C. elegans, PA did not influence the survival below 64 μg/mL. In this study PA demonstrated antifungal and antibiofilm activity against C. albicans and our results showed the potential of developing PA to fight Candida infections.
期刊介绍:
Pathogen genome sequencing projects have provided a wealth of data that need to be set in context to pathogenicity and the outcome of infections. In addition, the interplay between a pathogen and its host cell has become increasingly important to understand and interfere with diseases caused by microbial pathogens. IJMM meets these needs by focussing on genome and proteome analyses, studies dealing with the molecular mechanisms of pathogenicity and the evolution of pathogenic agents, the interactions between pathogens and host cells ("cellular microbiology"), and molecular epidemiology. To help the reader keeping up with the rapidly evolving new findings in the field of medical microbiology, IJMM publishes original articles, case studies and topical, state-of-the-art mini-reviews in a well balanced fashion. All articles are strictly peer-reviewed. Important topics are reinforced by 2 special issues per year dedicated to a particular theme. Finally, at irregular intervals, current opinions on recent or future developments in medical microbiology are presented in an editorial section.